HomeInsightsStock Comparison

Annapurna Swadisht Ltd vs Nath Bio Genes India Ltd Stock Comparison

Annapurna Swadisht Ltd vs Nath Bio Genes India Ltd Stock Comparison

Last Updated on: Oct 11, 2026

Key Highlights

  • The Latest Trading Price of Annapurna Swadisht Ltd is ₹ 125.14 as of 09 Oct 15:30 . The P/E Ratio of Annapurna Swadisht Ltd changed from 44.1 on March 2023 to 11.9 on March 2026 . This represents a CAGR of -27.93% over 4 yearsThe P/E Ratio of Nath Bio-Genes (India) Ltd changed from 7.7 on March 2023 to 5.8 on March 2026 . This represents a CAGR of -6.84% over 4 years The Market Cap of Annapurna Swadisht Ltd changed from ₹ 316.04 crore on March 2023 to ₹ 362.43 crore on March 2026 . This represents a CAGR of 3.48% over 4 yearsThe Market Cap of Nath Bio-Genes (India) Ltd changed from ₹ 405.45 crore on March 2022 to ₹ 242.59 crore on March 2026 . This represents a CAGR of -9.76% over 5 years The revenue of Annapurna Swadisht Ltd for the Jun '26 is ₹ 127.21 crore as compare to the Mar '26 revenue of ₹ 126.75 crore. This represent the growth of 0.36% The revenue of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 331.5 crore as compare to the Mar '26 revenue of ₹ 55.23 crore. This represent the growth of 500.22% The ebitda of Annapurna Swadisht Ltd for the Jun '26 is ₹ 21 crore as compare to the Mar '26 ebitda of ₹ 19.07 crore. This represent the growth of 10.12% The ebitda of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 38.25 crore as compare to the Mar '26 ebitda of ₹ 8.11 crore. This represent the growth of 371.64% The net profit of Annapurna Swadisht Ltd changed from ₹ 8.83 crore to ₹ 9.81 crore over 5 quarters. This represents a CAGR of 8.78% The net profit of Nath Bio-Genes (India) Ltd changed from ₹ 33.35 crore to ₹ 32.26 crore over 9 quarters. This represents a CAGR of -1.47% The Dividend Payout of Annapurna Swadisht Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Nath Bio-Genes (India) Ltd changed from 6.83 % on March 2021 to 8.55 % on March 2026 . This represents a CAGR of 3.81% over 6 years .

About Annapurna Swadisht Ltd

  • Annapurna Swadisht Limited was originally formed as Partnership Firm in the name of 'M/s Annapurna Agro Industries' through Partnership Deed dated November 27, 2015.
  • Further, the Partnership Firm converted into Private Limited Company 'Annapurna Swadisht Private Limited' on February 11, 2022.
  • Subsequently, Company got converted into a Public Limited Company and the name of the Company changed to 'Annapurna Swadisht Limited' on July 8, 2022. Promoters Mr. Ritesh Shaw and Mr. Shreeram Bagla were undertaking business of snacks and food products in the Annapurna Agro Industries.
  • The Firm incorporated in the year 2015, and it is being able to established itself as a brand name in the Eastern India.
  • Presently, the Company is manufacturer of snacks and food products, namely, Fryums, cakes, candys, namkeen, chips and Gohona Bori.

About Nath Bio-Genes (India) Ltd

  • Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
  • The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.

FAQs for the comparison of Annapurna Swadisht Ltd and Nath Bio-Genes (India) Ltd

Which company has a larger market capitalization, Annapurna Swadisht Ltd or Nath Bio-Genes (India) Ltd?

Market cap of Annapurna Swadisht Ltd is 273 Cr while Market cap of Nath Bio-Genes (India) Ltd is 261 Cr

What are the key factors driving the stock performance of Annapurna Swadisht Ltd and Nath Bio-Genes (India) Ltd?

The stock performance of Annapurna Swadisht Ltd and Nath Bio-Genes (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Annapurna Swadisht Ltd and Nath Bio-Genes (India) Ltd?

As of October 11, 2026, the Annapurna Swadisht Ltd stock price is INR ₹125.14. On the other hand, Nath Bio-Genes (India) Ltd stock price is INR ₹137.75.

How do dividend payouts of Annapurna Swadisht Ltd and Nath Bio-Genes (India) Ltd compare?

To compare the dividend payouts of Annapurna Swadisht Ltd and Nath Bio-Genes (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions